WSGR logoWSGR logo
Daniel Jordan
Associate
Corporate
Boston

D617-598-7836

Download vCard
Open PDF

Dan Jordan is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on advising technology, life sciences, and emerging growth companies in corporate and securities law matters through all stages of the business life cycle.

Prior to attending law school, Dan was a nuclear-trained submarine officer serving aboard USS Springfield (SSN-761) and USS South Dakota (SSN-790). Dan is currently a Lieutenant Commander with the Navy Reserve.

Experience

Dan Jordan is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on advising technology, life sciences, and emerging growth companies in corporate and securities law matters through all stages of the business life cycle.

Prior to attending law school, Dan was a nuclear-trained submarine officer serving aboard USS Springfield (SSN-761) and USS South Dakota (SSN-790). Dan is currently a Lieutenant Commander with the Navy Reserve.

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises QuantWare on $178 Million Series B
On May 5, 2026, QuantWare, a leading industrial quantum processor company, announced a $178 million Series B equity fundraising following the announcement of VIO-40K™, a quantum processor architecture for 10,000 qubits, 100x larger than the state of the art today. New investors joining the round include Intel Capital, IQT, and ETF Partners, with participating existing investors including FORWARD.one and Invest-NL Deep Tech Fund, InnovationQuarter Capital, Ground State Ventures, and Graduate Ventures. The round was heavily oversubscribed and is the largest private round raised by a dedicated quantum processor company to date. Wilson Sonsini Goodrich & Rosati advised QuantWare on the transaction.

QuantWare is the only company that designs, fabricates, and integrates modular quantum processors on an open architecture at an industrial scale. The company is building KiloFab, the world’s largest dedicated quantum open architecture fab, increasing its production capacity by 20x to meet strong global customer demand.

The Wilson Sonsini team that advised QuantWare on the financing included:

Corporate
Daniel Glazer
Michael Labriola
Ashmi Bhagani
Elisa Sielski
Michael Soud
Daniel Jordan
Henry Oates 
Learn More
Client Highlights
Wilson Sonsini Advises Cognito Therapeutics on Oversubscribed $105 Million Series C
On March 5, 2026, Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, announced the closing of an oversubscribed $105 million Series C financing round. Wilson Sonsini Goodrich & Rosati advised Cognito Therapeutics on the transaction.
Learn More
View All
WSGR logo
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.